Agilysys inc (AGYS)
CashFlow / Yearly
Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10
Less: Income from discontinued operations

-

-

-

-

-

-

19,992

4,916

14,710

-32,500

11,177

Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent

-

-

-

-

-

-

-2,895

-6,214

-37,493

-22,975

-7,630

Operating activities
Net loss

-34,067

-13,164

-8,350

-11,721

-3,765

-11,497

17,097

-1,298

-22,783

-55,475

3,547

Adjustments to reconcile net loss to net cash provided by operating activities:
Restructuring, severance and other charges

-

-

-

-

-

-

-

1,495

15,247

405

823

Net restructuring, severance and other charges

-

-

-

224

333

-134

349

6,673

5,896

-

-

Impairments

23,740

-

-

-

87

3,454

327

120

9,681

959

236

(Gain) loss on disposal of property & equipment

5

-17

-

-70

-381

0

0

-

-

-

-

Litigation Settlement, Expense

-

-

-

-

-

-

-

1,664

-

-

-

Legal settlements

-

-

-

-

-

-

-

-

0

0

-

Payments and settlements for restructuring

-

-

-

-

-

-

-

-

-

1,610

8,812

Net legal settlements

-

-

-

100

-185

1,511

110

0

0

-

-

Depreciation

2,574

2,504

2,631

2,409

2,199

2,225

2,074

2,137

3,963

3,914

3,260

Amortization of developed technology

-

-

-

8,012

1,022

1,294

-

-

-

-

-

Amortization of intangibles

2,541

2,567

1,879

1,392

1,243

3,461

6,726

4,089

5,807

7,343

6,619

Amortization of developed technology

12,561

12,602

10,016

-

-

-

-

-

-

-

-

Contingent consideration adjustment

-

-

-

-

93

-1,619

0

0

-

-

-

Loss on sale of securities

-

-

-

-

-

-

-

-

-

-

-91

Amortization of developed technology

12,561

12,602

10,016

-

-

-

-

-

-

-

-

Deferred income taxes

-356

309

-3,085

-142

-23

371

178

244

10

-4,449

3,383

Share-based compensation

5,205

4,376

4,688

2,427

3,405

3,140

2,119

1,638

2,397

2,812

1,947

Change in cash surrender value of company owned life insurance policies

-

-

-

18

564

57

600

107

371

-

802

Gain on redemption of investment in The Reserve Fund's Primary Fund

-

-

-

-

-

-

-

-

-

-

2,505

Excess tax benefit from equity awards

-

-

-

-

-

14

37

0

0

-

9

Gain on redemption of corporate-owned life insurance policies

-

-

-

-

-

-

-

-

-

2,065

-

Accounts receivable

8,974

7,536

719

-6,372

-3,237

1,935

7,846

741

3,396

-10,256

-5,925

Contract assets

-794

-1,662

-

-

-

-

-

-

-

-

-

Increase (Decrease) in Contract with Customer, Asset

-

-

-

0

-

-

-

-

-

-

-

Inventories

1,830

50

-229

-476

2,051

171

-380

-426

645

859

-3,261

Prepaid expense and other current assets

-1,545

1,158

-1,485

-1,946

4,532

526

498

801

207

609

-

Accounts payable

8,585

-3,512

130

554

-7,896

5,528

1,073

1,595

-1,700

-20,477

9,788

Contract liabilities

3,563

4,845

-2,448

-4,034

9,364

1,146

2,784

-5,046

7,775

2,865

4,796

Accrued liabilities

-4,227

5,029

653

-4,250

5,330

-3,868

1,624

-3,170

-2,600

-2,499

-17,255

Income taxes payable

-153

-564

-19

45

16

-823

-2,702

-2,960

-5,958

7,562

-9,021

Other changes, net

-921

-686

-216

-65

-226

-176

-

-

-

-

-

Changes in operating assets and liabilities

-

-

-

-

-

-

508

258

-727

-1,615

-3,926

Net cash provided by (used in) operating activities from continuing operations

-

-

-

-

-

-

1,384

-13,050

-12,679

-8,914

-1,979

Net cash used in operating activities from discontinued operations

-

-

-

-

-

-

-1,311

2,345

-9,019

23,697

105,903

Net cash provided by operating activities

10,575

7,241

6,874

3,433

7,218

-2,186

73

-10,705

-21,698

14,783

103,924

Investing activities
Proceeds from sale of business units

-

-

-

-

-

809

35,846

0

55,840

0

-

Cash paid for acquisitions, net

-

-

-

-

-

3,750

1,812

0

0

-

-

Investment in marketable securities

-

-

-

-

-

10,240

0

0

-

13,731

45

Proceeds from sale of marketable securities

-

-

-

-

-

10,107

0

4,347

9,184

161

61

Additional investments in corporate-owned life insurance policies and marketable securities

-

-

-

-

-

-

-

-

-

-

1,712

Proceeds from redemption of/borrowings against corporate-owned life insurance policies

-

-

-

-

-

-

-

-

-

-

12,500

Capital expenditures

3,420

3,318

6,140

4,158

5,900

4,650

4,023

2,532

2,231

3,427

13,203

Capitalized software development costs

-

2,189

8,918

11,888

15,048

15,813

12,200

3,906

2,585

2,650

-

Additional (investments in) corporate-owned life insurance policies

27

27

27

-2,181

65

-1,905

87

108

-235

-14,851

-

Proceeds from The Reserve Fund's Primary Fund

-

-

-

-

-

-

-

-

-

-

4,772

Net cash (used in) provided by investing activities from continuing operations

-

-

-

-

-

-

17,724

-2,199

60,443

-4,796

2,373

Net cash used in investing activities from discontinued operations

-

-

-

-

-

-

-155

-854

-104

-914

-103

Net cash used in investing activities

-3,447

-5,534

-15,085

-13,865

-21,013

-21,632

17,569

-3,053

60,339

-5,710

2,270

Exercise of employee stock options

-

-

-

-

-

102

169

67

210

0

89

Repurchase of common shares to satisfy employee tax withholding

1,092

647

1,171

533

435

373

912

278

1,449

238

-

Payments to settle contingent consideration arising from business acquisitions

-

-

-

-197

0

0

-

-

-

-

-

Principal payments under long-term obligations

24

120

124

117

142

144

177

289

1,001

370

216

Floor plan financing agreement, net

-

-

-

-

-

-

-

-

-

-

-6,575

Debt financing costs

-

-

-

-

-

-

-

-

-

-

1,578

Excess tax benefit from equity awards

-

-

-

-

-

14

37

0

0

-

9

Repurchase of common shares

-

-

-

-

-

-

-

-

13,173

0

-

Proceeds from borrowings under credit facility

-

-

-

-

-

-

-

-

-

15,235

5,077

Principal payments under credit facility

-

-

-

-

-

-

-

-

-

15,235

5,077

Dividends paid

-

-

-

-

-

-

-

-

-

-

1,360

Net cash used in financing activities

-

-

-

-847

-577

-401

-883

-500

-15,413

-608

-9,631

Net cash used in financing activities from discontinued operations

-

-

-

-

-

-

-80

-377

0

-49

-67,893

Net cash used in financing activities

-1,116

-767

-1,295

-

-

-

-963

-877

-15,413

-657

-77,524

Effect of exchange rate changes on cash

-130

-112

194

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

5,882

828

-9,312

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash

-

-

-

-74

-87

-280

-44

-21

5

403

414

Cash flows (used in) provided by continuing operations

-

-

-

-

-

-

18,181

-15,770

32,356

-13,915

-8,823

Cash flows used in discontinued operations

-

-

-

-

-

-

-1,546

1,114

-9,123

22,734

37,907

Net decrease in cash and cash equivalents

-

-

-

-11,353

-14,459

-24,499

16,635

-14,656

23,233

8,819

29,084